Another potential mechanism underlying TMP’s anti-AD’s effects involves the downregulation of Cullin 4B (CUL4B) in the brain tissue of AD mice, which inhibits the ubiquitination of somatostatin receptor 4 (SSRT4) and upregulates SSRT4 protein levels. Here, CUL4B is linked to Alzheimer disease.